|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q62589526
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010842.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q62589526
|
|
024
|
|
|
‡a
0000-0002-2390-5473
‡2
orcid
|
|
024
|
|
|
‡a
36793758400
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q62589526
|
|
100
|
0 |
|
‡a
Margarida M Moura
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Margarida M Moura
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas
|
|
670
|
|
|
‡a
Author's High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.
|
|
670
|
|
|
‡a
Author's Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma.
|
|
670
|
|
|
‡a
Author's Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas
|
|
670
|
|
|
‡a
Author's Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's RAS proto-oncogene in medullary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
|
|
909
|
|
|
‡a
(orcid) 0000000223905473
‡9
1
|
|
909
|
|
|
‡a
(scopus) 36793758400
‡9
1
|
|
919
|
|
|
‡a
cellcyclederegulationandtp53andrasmutationsaremajoreventsinpoorlydifferentiatedandundifferentiatedthyroidcarcinomas
‡A
Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
identificationandcharacterizationof2novelgermlineretvariantsassociatedwithmedullarythyroidcarcinoma
‡A
Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma.
‡9
1
|
|
919
|
|
|
‡a
identificationofsomatictertpromotermutationsinfamilialnonmedullarythyroidcarcinomas
‡A
Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
osteopontinexpressioniscorrelatedwithdifferentiationandgoodprognosisinmedullarythyroidcarcinoma
‡A
Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
rasprotooncogeneinmedullarythyroidcarcinoma
‡A
RAS proto-oncogene in medullary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
tertpromotermutationsareamajorindicatorofpooroutcomeindifferentiatedthyroidcarcinomas
‡A
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
highprevalenceofrasmutationsinretnegativesporadicmedullarythyroidcarcinomas
‡A
High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.
‡9
1
|
|
996
|
|
|
‡2
DNB|1056637897
|
|
996
|
|
|
‡2
ISNI|0000000028490081
|
|
996
|
|
|
‡2
PTBNP|249569
|
|
996
|
|
|
‡2
ISNI|0000000069887595
|
|
996
|
|
|
‡2
PTBNP|1901499
|
|
996
|
|
|
‡2
ISNI|0000000070538384
|
|
996
|
|
|
‡2
ISNI|0000000070426817
|
|
996
|
|
|
‡2
PTBNP|100101
|
|
996
|
|
|
‡2
PTBNP|1785417
|
|
996
|
|
|
‡2
BLBNB|000302437
|
|
996
|
|
|
‡2
BLBNB|000202242
|
|
996
|
|
|
‡2
LC|n 2024053351
|
|
996
|
|
|
‡2
ISNI|0000000070909704
|
|
996
|
|
|
‡2
PTBNP|918936
|
|
996
|
|
|
‡2
NII|DA17872669
|
|
996
|
|
|
‡2
PTBNP|1159856
|
|
996
|
|
|
‡2
LC|n 86052014
|
|
996
|
|
|
‡2
PTBNP|122472
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
